Vibecotamab (XmAb14045)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vibecotamab (XmAb14045), covering 2026-04-16 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure [Phase 2]